Thus, our data establish pltPCSK9 as a relevant factor for atherothrombosis and thrombo-inflammation, which might at least partially be relevant for the highly efficient effects of PCSK9 inhibitors to reduce mortality and other adverse cardiovascular events in coronary artery disease. The gene discussed is PCSK9; the disease is coronary artery disorder.